CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- ScaleRevenue is $857.5M, above the global median of $520.53M
- FinancialsAltman Z-Score 1.6: grey zone
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
444.65MUSDvs all stocks (USD)
Revenue (TTM)
857.50MUSDvs all stocks (USD)
Profit Margin
-9.64%vs Medical Devices peers
Beta
0.8960xvs all stocks
52-Week Change
42.47%vs all stocks
Market Capitalization
444.65MUSDvs all stocks (USD)
Enterprise Value
750.76MUSDvs all stocks (USD)
Forward P/E
9.92xvs Medical Devices peers
Price to Sales (TTM)
0.5185xvs Medical Devices peers
Price to Book (MRQ)
0.9377xvs Medical Devices peers
Enterprise to Revenue
0.8760xvs Medical Devices peers
Enterprise to EBITDA
8.37xvs Medical Devices peers
Gross Margin
33.61%vs Medical Devices peers
Profit Margin
-9.64%vs Medical Devices peers
Operating Margin
6.67%vs Medical Devices peers
Return on Assets (TTM)
3.20%vs Medical Devices peers
Return on Equity (TTM)
-15.68%vs Medical Devices peers
Revenue (TTM)
857.50MUSDvs all stocks (USD)
Revenue per Share (TTM)
20.54USDUpdated Jul 19, 2026Quarterly Revenue Growth
1.50%vs Medical Devices peers
Gross Profit (TTM)
287.70MUSDvs all stocks (USD)
EBITDA (TTM)
89.40MUSDvs all stocks (USD)
Net Income (TTM)
-82.70MUSDvs all stocks (USD)
Operating Cash Flow (TTM)
-2.00MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
-40.27MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Jul 19, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Medical Devices peers
Minority Interest (Equity)
14.00MUSDFY2025 · Sep 30, 2025Revenue
844.60MUSDFY2025 · Sep 30, 2025Cost of Goods Sold
554.10MUSDFY2025 · Sep 30, 2025Gross Profit
290.50MUSDFY2025 · Sep 30, 2025Operating Income
66.10MUSDvs all stocks (USD)
Pre-tax Income
-59.20MUSDFY2025 · Sep 30, 2025Income Tax Expense
10.70MUSDFY2025 · Sep 30, 2025Net Income
-69.90MUSDFY2025 · Sep 30, 2025EBIT
-26.50MUSDFY2025 · Sep 30, 2025EBITDA (Income Statement)
97.60MUSDFY2025 · Sep 30, 2025Research & Development
91.10MUSDFY2025 · Sep 30, 2025Selling, General & Administrative
133.30MUSDFY2025 · Sep 30, 2025Non-operating Interest Income
8.50MUSDFY2025 · Sep 30, 2025Non-operating Interest Expense
32.70MUSDFY2025 · Sep 30, 2025EPS (Basic)
-1.70USDFY2025 · Sep 30, 2025EPS (Diluted)
-1.70USDFY2025 · Sep 30, 2025Basic Shares Outstanding
41.40MSharesFY2025 · Sep 30, 2025Diluted Shares Outstanding
41.40MSharesFY2025 · Sep 30, 2025Net Income from Continuing Operations
-69.90MUSDFY2025 · Sep 30, 2025Minority Interests (P&L)
-400.00KUSDFY2025 · Sep 30, 2025Operating Cash Flow
-55.20MUSDFY2025 · Sep 30, 2025Free Cash Flow
-78.10MUSDFY2025 · Sep 30, 2025Cash & Cash Equivalents (End of Period)
147.10MUSDFY2025 · Sep 30, 2025Income Tax Paid
18.60MUSDFY2025 · Sep 30, 2025Interest Paid
31.30MUSDFY2025 · Sep 30, 2025Starting Profit (CF Statement)
-69.90MUSDFY2025 · Sep 30, 2025Depreciation & Amortization
27.20MUSDFY2025 · Sep 30, 2025Deferred Taxes (CF)
-500.00KUSDFY2025 · Sep 30, 2025Stock-based Compensation
15.00MUSDFY2025 · Sep 30, 2025Other Non-cash Items
900.00KUSDFY2025 · Sep 30, 2025Change in Accounts Receivable (CF)
100.00KUSDFY2025 · Sep 30, 2025Change in Accounts Payable (CF)
6.20MUSDFY2025 · Sep 30, 2025Change in Other Assets/Liabilities
-34.20MUSDFY2025 · Sep 30, 2025Capital Expenditures
-22.90MUSDFY2025 · Sep 30, 2025Net Acquisitions
0.00USDFY2025 · Sep 30, 2025Purchase of Investments
-31.40MUSDFY2025 · Sep 30, 2025Sale of Investments
65.40MUSDFY2025 · Sep 30, 2025Other Investing Activity
-800.00KUSDFY2025 · Sep 30, 2025Net Investing Cash Flow
10.30MUSDFY2025 · Sep 30, 2025Long-term Debt Issuance
126.90MUSDFY2025 · Sep 30, 2025Long-term Debt Payments
-201.90MUSDFY2025 · Sep 30, 2025Other Financing Charges
-4.20MUSDFY2025 · Sep 30, 2025Net Financing Cash Flow
-79.20MUSDFY2025 · Sep 30, 2025Shares Outstanding
42.15MSharesUpdated Jul 19, 2026Float Shares
41.40MSharesUpdated Jul 19, 2026Shares Short
1.31MSharesUpdated Jul 19, 2026Short Ratio
2.72daysvs all stocks
Short % of Shares Outstanding
3.50%vs all stocks
% Held by Insiders
1.66%vs all stocks
% Held by Institutions
100.21%vs all stocks
Total Cash (MRQ)
88.30MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
2.10USDUpdated Jul 19, 2026Total Debt (MRQ)
381.00MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.7806xvs Medical Devices peers
Current Ratio (MRQ)
3.20xvs Medical Devices peers
Book Value per Share (MRQ)
11.25USDUpdated Jul 19, 2026Total Assets
1.11BUSDvs all stocks (USD)
Total Current Assets
641.80MUSDFY2025 · Sep 30, 2025Total Liabilities
620.80MUSDFY2025 · Sep 30, 2025Total Non-current Assets
465.60MUSDFY2025 · Sep 30, 2025Total Non-current Liabilities
433.60MUSDFY2025 · Sep 30, 2025Total Current Liabilities
187.20MUSDFY2025 · Sep 30, 2025Cash & Cash Equivalents
145.00MUSDFY2025 · Sep 30, 2025Other Short-term Investments
10.10MUSDFY2025 · Sep 30, 2025Accounts Receivable
156.60MUSDFY2025 · Sep 30, 2025Inventory
299.40MUSDFY2025 · Sep 30, 2025Accounts Payable
69.90MUSDFY2025 · Sep 30, 2025Short-term Debt
5.90MUSDFY2025 · Sep 30, 2025Deferred Revenue
13.00MUSDFY2025 · Sep 30, 2025Other Current Liabilities
20.00MUSDFY2025 · Sep 30, 2025Long-term Debt
390.00MUSDFY2025 · Sep 30, 2025Other Non-current Liabilities
29.60MUSDFY2025 · Sep 30, 2025Common Stock (Book)
400.00KUSDFY2025 · Sep 30, 2025Retained Earnings
-5.90MUSDFY2025 · Sep 30, 2025Total Shareholders' Equity
486.60MUSDvs all stocks (USD)
52-Week Low
6.76USDUpdated Jul 19, 202652-Week High
14.56USDUpdated Jul 19, 202652-Week Change
42.47%vs all stocks
Beta
0.8960xvs all stocks
50-Day MA
10.41USDUpdated Jul 19, 2026200-Day MA
11.69USDUpdated Jul 19, 2026Avg 10-Day Volume
389.35KSharesUpdated Jul 19, 2026Avg 30-Day Volume
439.22KSharesUpdated Jul 19, 2026Diluted EPS (TTM)
-1.96USDUpdated Jul 19, 2026Other Income / Expense
-98.30MUSDFY2025 · Sep 30, 2025Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 1.6: grey zoneSignificant
Altman Z-Score: 1.60
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Scale
Revenue is $857.5M, above the global median of $520.53MNotable
Revenue (USD): 857,500,032Global Median: 520,528,949.311
Companies that share the same coordination system — how they create, deliver, or capture value.
Shoulder Innovations, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Rezolute, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Jw Pharmaceutical Corporation
Tier 1ProductionApproval-Gated PipelineRuleFlow
Clover Biopharmaceuticals Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Zhejiang Haisen Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Delcath Systems Inc.
Tier 1ProductionApproval-Gated PipelineRule
Pacific Biosciences of California, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Baotou Dongbao Bio-Tech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Honz Pharmaceutical Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Jiangxi Synergy Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow